Inaktiver Wert

CardioDx Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

CardioDx : New Study Published in The American Journal of Medicine Expands the Clinical Evidence Underscoring the Value of the Corus® CAD Blood Test to Help Safely Direct Cardiovascular Care	12.04.17
CardioDx : Announces Results of Study Demonstrating the Benefits of the Corus CAD Gene Expression Test Use in an African American Patient Population	22.10.14
CardioDx : Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test	08.07.14
CardioDx : New Study Results Further Reinforce that the Corus® CAD Test Helps Primary Care Clinicians Make Effective Referral Decisions for Patients with Suspected Obstructive Coronary Artery Disease	08.05.14
CardioDx : and Medison Israel Enter Into an Exclusive Corus® CAD Product Marketing and Sales Agreement	10.04.14

Sektor

	% 1. Jan.	Kap.
BIOMÉRIEUX	-1,89 %	12,56 Mrd.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9,59 %	7,68 Mrd.
DIASORIN S.P.A.	-1,31 %	5,29 Mrd.
LANTHEUS HOLDINGS, INC.	+21,82 %	5,24 Mrd.
AUTOBIO DIAGNOSTICS CO., LTD.	+0,02 %	4,57 Mrd.
10X GENOMICS, INC.	-50,89 %	3,29 Mrd.
ANDON HEALTH CO., LTD.	+6,42 %	2,6 Mrd.
VITROLIFE AB	-10,02 %	2,2 Mrd.
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8,29 %	1,79 Mrd.